India considers policy change after cough syrup deaths, a document from PM’s office
GSK to bounce regulatory submissions for experimental arthritis drug
High expectations from the draft Bill
OTC Drugs and E-Pharmacies: High time for regulation?
SII writes letter to PMO recommending reforms in drug regulatory system
BDR Pharma urges regulators to expedite manufacturing, marketing license process for remdesivir